0.60Open0.60Pre Close0 Volume4 Open Interest10.00Strike Price0.00Turnover341.96%IV45.13%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.60Extrinsic Value100Contract SizeAmericanOptions Type-0.1041Delta0.0193Gamma28.55Leverage Ratio-0.0905Theta-0.0006Rho-2.97Eff Leverage0.0050Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet